D.E. Shaw & Co’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Hold |
25,720
| – | – | ﹤0.01% | 2709 |
|
|
2025
Q1 | $297K | Sell |
25,720
-47,566
| -65% | -$549K | ﹤0.01% | 2651 |
|
|
2024
Q4 | $621K | Sell |
73,286
-16,643
| -19% | -$141K | ﹤0.01% | 2309 |
|
|
2024
Q3 | $1.04M | Sell |
89,929
-10,132
| -10% | -$117K | ﹤0.01% | 2152 |
|
|
2024
Q2 | $1.18M | Buy |
100,061
+12,968
| +15% | +$153K | ﹤0.01% | 2093 |
|
|
2024
Q1 | $1.03M | Sell |
87,093
-1,670
| -2% | -$19.8K | ﹤0.01% | 2092 |
|
|
2023
Q4 | $1.09M | Sell |
88,763
-26,519
| -23% | -$325K | ﹤0.01% | 2031 |
|
|
2023
Q3 | $1.11M | Sell |
115,282
-1,580
| -1% | -$15.2K | ﹤0.01% | 1989 |
|
|
2023
Q2 | $1.05M | Buy |
116,862
+71,198
| +156% | +$641K | ﹤0.01% | 2052 |
|
|
2023
Q1 | $359K | Buy |
45,664
+1,851
| +4% | +$14.5K | ﹤0.01% | 2624 |
|
|
2022
Q4 | $296K | Sell |
43,813
-456
| -1% | -$3.08K | ﹤0.01% | 2901 |
|
|
2022
Q3 | $642K | Sell |
44,269
-10,707
| -19% | -$155K | ﹤0.01% | 2760 |
|
|
2022
Q2 | $541K | Buy |
+54,976
| New | +$541K | ﹤0.01% | 3008 |
|
|
2020
Q3 | – | Sell |
-14,705
| Closed | -$178K | – | 2666 |
|
|
2020
Q2 | $178K | Buy |
+14,705
| New | +$178K | ﹤0.01% | 2474 |
|